| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 16.853 | 42.545 | 30.366 | - | - |
| Total Income - EUR | - | - | - | - | - | 16.853 | 42.545 | 30.366 | - | - |
| Total Expenses - EUR | - | - | - | - | - | 2.042 | 8.724 | 6.631 | - | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | 14.811 | 33.822 | 23.735 | - | - |
| Net Profit/Loss - EUR | - | - | - | - | - | 14.651 | 33.447 | 23.477 | - | - |
| Employees | - | - | - | - | - | 2 | 1 | 1 | - | - |
Check the financial reports for the company - Medoliv S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 57.129 | - | - |
| Current Assets | - | - | - | - | - | 15.274 | 49.657 | 15.289 | - | - |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Receivables | - | - | - | - | - | 0 | 47.196 | 9.727 | - | - |
| Cash | - | - | - | - | - | 15.274 | 2.461 | 5.562 | - | - |
| Shareholders Funds | - | - | - | - | - | 14.692 | 47.814 | 71.440 | - | - |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | - | - |
| Debts | - | - | - | - | - | 582 | 1.843 | 979 | - | - |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medoliv S.r.l.